Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F10%3A00002286" target="_blank" >RIV/00023001:_____/10:00002286 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study

Original language description

The Symphony study assessed whether mycophenolate mofetil (MMF)-based regimens containing reduced doses of adjunct immunosuppressants could reduce toxicity while maintaining efficacy. Here, we examined the impact of acute rejection and associated risk factors. The incidence of biopsy-proven acute rejection in the low-dose tacrolimus group was approximately half that of the standard-dose cyclosporine and low-dose cyclosporine groups, and a third of that in the low-dose sirolimus group. The low-dose cyclosporine group had more severe rejection episodes (>=grade II) compared with other groups.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FE - Other fields of internal medicine

OECD FORD branch

—

Project

—

Continuities

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Publication year

2010

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Clinical transplantation

ISSN

0902-0063

e-ISSN

—

Volume of the periodical

24

Issue of the periodical within the volume

4

Country of publishing house

DK - DENMARK

Number of pages

10

Pages from-to

—

UT code for WoS article

000280991700016

EID of the result in the Scopus database

—